Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP228526.RA_HWQZoN9qlqd3R-irXG0PH5WJHqeYjJUjfbZ18rh2uQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP228526.RA_HWQZoN9qlqd3R-irXG0PH5WJHqeYjJUjfbZ18rh2uQ130_assertion type Assertion NP228526.RA_HWQZoN9qlqd3R-irXG0PH5WJHqeYjJUjfbZ18rh2uQ130_head.
- NP228526.RA_HWQZoN9qlqd3R-irXG0PH5WJHqeYjJUjfbZ18rh2uQ130_assertion description "[Finally, RARA may be the key to unlocking the problem of resistance to all-trans retinoic acid (ATRA) in breast cancer sufferers; this treatment has previously been demonstrated to induce remission in over 80% of patients with acute promyelocytic leukaemia (APML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP228526.RA_HWQZoN9qlqd3R-irXG0PH5WJHqeYjJUjfbZ18rh2uQ130_provenance.
- NP228526.RA_HWQZoN9qlqd3R-irXG0PH5WJHqeYjJUjfbZ18rh2uQ130_assertion evidence source_evidence_literature NP228526.RA_HWQZoN9qlqd3R-irXG0PH5WJHqeYjJUjfbZ18rh2uQ130_provenance.
- NP228526.RA_HWQZoN9qlqd3R-irXG0PH5WJHqeYjJUjfbZ18rh2uQ130_assertion SIO_000772 20100636 NP228526.RA_HWQZoN9qlqd3R-irXG0PH5WJHqeYjJUjfbZ18rh2uQ130_provenance.
- NP228526.RA_HWQZoN9qlqd3R-irXG0PH5WJHqeYjJUjfbZ18rh2uQ130_assertion wasDerivedFrom befree-20140225 NP228526.RA_HWQZoN9qlqd3R-irXG0PH5WJHqeYjJUjfbZ18rh2uQ130_provenance.
- NP228526.RA_HWQZoN9qlqd3R-irXG0PH5WJHqeYjJUjfbZ18rh2uQ130_assertion wasGeneratedBy ECO_0000203 NP228526.RA_HWQZoN9qlqd3R-irXG0PH5WJHqeYjJUjfbZ18rh2uQ130_provenance.